NL-OMON36040
Recruiting
Not Applicable
Tumor response assessment in breast cancer patients receiving neoadjuvant systemic therapy using optical mammography: the Softscan Study - The Softscan Study
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- breast cancer
- Sponsor
- eids Universitair Medisch Centrum
- Enrollment
- 42
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •breast cancer patients to receive neoadjuvant systemic therapy
Exclusion Criteria
- •breast implants
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Tumorresponse monitoring in patients with breast cancer treated with primary systemic therapy: Towards predicting response in both the primary tumor and in axillary lymph nodesbreast cancercarcinoma10006291NL-OMON31961Antoni van Leeuwenhoek Ziekenhuis300
Recruiting
Not Applicable
Onderzoek naar het bepalen van de reactie op chemotherapie van tumorcellen in de borst en in de oksel.breast cancerneoadjuvant chemotherapyaxillary lymph node metastasisFDG-PET/CTIodine-125 seedsNL-OMON21498Philips300
Recruiting
Not Applicable
Clinical performance study of breast cancer prognostic diagnosticsGenesWell™ BCT in Korean patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative early breast cancerKCT0004263Samsung Medical Center500
Recruiting
Not Applicable
Verification of the effectiveness of breast cancer education for healthy peoplehealthy peopleJPRN-UMIN000046287Tokyo Medical and Dental Univ.300
Active, not recruiting
Phase 1
Pivotal study in breast cancer patients investigating efficacy and safety of LA-EP2006 and Neulasta®Breast CancerTherapeutic area: Diseases [C] - Cancer [C04]EUCTR2012-002039-28-ESSandoz GmbH308